BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15603873)

  • 21. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
    Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
    Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.
    Cetin E; Cengiz B; Gunduz E; Gunduz M; Nagatsuka H; Bekir-Beder L; Fukushima K; Pehlivan D; N MO; Nishizaki K; Shimizu K; Nagai N
    Neoplasma; 2008; 55(4):299-304. PubMed ID: 18505340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
    dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR
    Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers.
    Adamson R; Jones AS; Field JK
    Oncogene; 1994 Jul; 9(7):2077-82. PubMed ID: 8208554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent loss of the long arm of chromosome 18 in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 May; 17(5):1005-11. PubMed ID: 17390036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
    Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
    Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
    Adams J; Williams SV; Aveyard JS; Knowles MA
    Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?
    Szukała K; Sowińska A; Wierzbicka M; Biczysko W; Szyfter W; Szyfter K
    Mutat Res; 2006 Aug; 600(1-2):67-76. PubMed ID: 16814812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel region of deletion on 13q33-q34 in esophageal squamous cell carcinoma.
    Guo GM; Huang XP; Dong JT; Caia Y; Xu X; Han YL; Wu M; Zhan QM; Wang MR
    Oncol Rep; 2005 Dec; 14(6):1639-46. PubMed ID: 16273270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region.
    Kujawski M; Jarmuz M; Rydzanicz M; Szukala K; Wierzbicka M; Grenman R; Golusinski W; Szyfter K
    Cancer Lett; 2004 May; 208(1):95-101. PubMed ID: 15105051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.
    Koene G; Mulder A; van der Ven K; Eijsink C; Franke M; Slootweg P; Claas F; Tilanus M
    Hum Immunol; 2006 Sep; 67(9):692-9. PubMed ID: 17002899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma.
    Kirkpatrick H; Waber P; Hoa-Thai T; Barnes R; Osborne-Lawrence S; Truelson J; Nisen P; Bowcock A
    Oncogene; 1997 May; 14(18):2189-93. PubMed ID: 9174054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.